Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 efficacy and safety assessment of intracameral T2380 in cataract surgery
2010-021188-34Phase 3Completed
- Sponsor
- Laboratoires Théa
- Start
- Apr 2011
- Modality
- Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3 trial of Mydrane in cataract (2 arms), sponsored by Laboratoires Théa. Primary endpoints: Primary efficacy endpoint and Co-primary efficacy endpoint. Started Apr 2011; status: completed.
02
Drugs
Mydrane
03
Conditions
cataract
Beyond the preview
Go deeper on 2010-021188-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-021188-34.